BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15028366)

  • 21. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of exercise training session duration in the rehabilitation of coronary artery disease patients.
    Hansen D; Dendale P; Berger J; Onkelinx S; Reyckers I; Hermans A; Vaes J; Reenaers V; Meeusen R
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):453-9. PubMed ID: 18677171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
    Holcombe SM; Brubaker PH
    J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of phase II cardiac rehabilitation programme on patients undergone coronary bypass surgery].
    Ciftçi C; Duman BS; Cağatay P; Demiroğlu C; Aytekin V
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):116-21. PubMed ID: 15939686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum magnesium and C-reactive protein levels.
    Rodríguez-Morán M; Guerrero-Romero F
    Arch Dis Child; 2008 Aug; 93(8):676-80. PubMed ID: 17641003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of rehabilitation in coronary artery disease patients: randomized clinical trial of the impact of exercise volume.
    Hansen D; Dendale P; Raskin A; Schoonis A; Berger J; Vlassak I; Meeusen R
    Clin Rehabil; 2010 Apr; 24(4):319-27. PubMed ID: 20176771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J
    Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients.
    Lavie CJ; Morshedi-Meibodi A; Milani RV
    J Cardiometab Syndr; 2008; 3(3):136-40. PubMed ID: 18983328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L; Zhao SP; Hu M; Li JX
    Coron Artery Dis; 2007 Sep; 18(6):489-93. PubMed ID: 17700222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P
    Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
    Morrow DA; de Lemos JA; Sabatine MS; Wiviott SD; Blazing MA; Shui A; Rifai N; Califf RM; Braunwald E
    Circulation; 2006 Jul; 114(4):281-8. PubMed ID: 16847150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modification of the lipid profile in coronary patients undergoing cardiac rehabilitation].
    Brízida L; Mendes M; Adegas A; Seabra-Gomes R
    Rev Port Cardiol; 1996 Dec; 15(12):877-83, 863-4. PubMed ID: 9052963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs.
    Savage PD; Banzer JA; Balady GJ; Ades PA
    Am Heart J; 2005 Apr; 149(4):627-31. PubMed ID: 15990744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
    Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of ambulatory supervised cardiac training on arterial hypertension in patients with coronary artery disease and arterial hypertension].
    Kałka D; Sobieszczańska M; Marciniak W; Popielewicz-Kautz A; Markuszewski L; Chorebała A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Jan; 22(127):9-14. PubMed ID: 17477082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.